Salarius Pharmaceuticals, Inc. (SLRX) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -1.65M | -862.3K | -1.18M | -742.52K | -1.36M | -1.07M | -1.35M | -1.51M | -3.75M | -4.42M | -3.17M | -4.71M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -21.38% | 19.58% | 12.72% | 50.87% | 63.81% | 75.72% | 57.28% | 67.94% | 34.7% | -22.01% | 9.98% | -73.26% |
| Net Income | -873.47K | -957.83K | -1.71M | -1.46M | -972.12K | -1.42M | -1.72M | -881.8K | -2.44M | -3.88M | -5.34M | -6.37M |
| Depreciation & Amortization | 1.11K | 1.11K | 1.11K | 1.11K | 1.1K | 1.11K | 1.11K | 1.1K | 5.61K | 1.67K | 1.67K | 1.67K |
| Stock-Based Compensation | 22.85K | 23.16K | 33.53K | 51.05K | 60.01K | 85.17K | 77.51K | 85.38K | 112.66K | 123.46K | 203.34K | 145.51K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -573.37K | 0 | 94.09K | 1.9M | 0 |
| Other Non-Cash Items | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 573.37K | 130K | -94.09K | -1.9M | -1.88K |
| Working Capital Changes | -797.17K | 71.27K | 493.18K | 669.26K | -445.67K | 265.97K | 282.72K | -715.91K | -1.55M | -664.27K | 1.97M | 1.51M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.48M | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -310.84K | 83.33K | 254.65K | 771.19K | -453.67K | -94.49K | 111.1K | -485.79K | -1.1M | -1.3M | 627.58K | 1.14M |
| Cash from Investing | -200K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -200K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 5.86M | -141.2K | 545.57K | -106.98K | 1.37M | -28.19K | -172.75K | -169.45K | -211.83K | 6.68M | 336.68K | 0 |
| Debt Issued (Net) | 0 | -112.23K | -109.64K | -106.98K | -69.88K | -116.86K | -172.79K | -169.45K | -111.47K | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | -28.97K | 655.2K | 0 | 1000K | 88.67K | 38 | 0 | -100.36K | 1000K | 336.68K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 5.86M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 4.01M | -1M | -636.15K | -849.5K | 11.21K | -1.1M | -1.53M | -1.68M | -3.96M | 2.27M | -2.83M | -4.71M |
| Free Cash Flow | -1.65M | -862.3K | -1.18M | -742.52K | -1.36M | -1.07M | -1.35M | -1.51M | -3.75M | -4.42M | -3.17M | -4.71M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -21.38% | 19.58% | 12.72% | 50.87% | 63.81% | 75.72% | 57.28% | 67.94% | 34.7% | -22.01% | 36.87% | -73.26% |
| FCF per Share | -3.42 | -6.06 | -10.60 | -11.52 | -15.80 | -26.65 | -38.54 | -45.82 | -119.24 | -194.65 | -158.21 | -249.76 |
| FCF Conversion (FCF/Net Income) | 1.89x | 0.90x | 0.69x | 0.51x | 1.40x | 0.75x | 0.79x | 1.71x | 1.53x | 1.14x | 0.59x | 0.74x |
| Interest Paid | 0 | 1.71K | 0 | -1.42K | 7.25K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |